TALOTTA, Rossella
 Distribuzione geografica
Continente #
EU - Europa 4.421
NA - Nord America 4.212
AS - Asia 3.005
SA - Sud America 990
Continente sconosciuto - Info sul continente non disponibili 380
AF - Africa 79
OC - Oceania 3
Totale 13.090
Nazione #
US - Stati Uniti d'America 4.096
RU - Federazione Russa 2.486
SG - Singapore 1.424
BR - Brasile 858
CN - Cina 644
IE - Irlanda 644
SE - Svezia 420
HK - Hong Kong 338
IT - Italia 290
FR - Francia 146
DE - Germania 122
IN - India 119
VN - Vietnam 116
BD - Bangladesh 82
GB - Regno Unito 78
CA - Canada 52
FI - Finlandia 47
IQ - Iraq 47
AR - Argentina 44
PL - Polonia 43
TR - Turchia 28
MX - Messico 27
ZA - Sudafrica 27
UA - Ucraina 26
BE - Belgio 23
NL - Olanda 21
AT - Austria 20
CO - Colombia 18
JP - Giappone 18
UZ - Uzbekistan 18
VE - Venezuela 18
EC - Ecuador 16
AE - Emirati Arabi Uniti 15
PK - Pakistan 14
EG - Egitto 13
ID - Indonesia 13
SA - Arabia Saudita 13
ES - Italia 12
PH - Filippine 11
AZ - Azerbaigian 10
CL - Cile 10
JO - Giordania 10
PY - Paraguay 10
IR - Iran 9
KE - Kenya 9
PE - Perù 9
KZ - Kazakistan 8
MA - Marocco 8
MY - Malesia 8
DO - Repubblica Dominicana 7
NP - Nepal 7
BO - Bolivia 6
IL - Israele 6
OM - Oman 6
AL - Albania 5
BG - Bulgaria 5
CZ - Repubblica Ceca 5
DZ - Algeria 5
HN - Honduras 5
KG - Kirghizistan 5
SN - Senegal 5
SV - El Salvador 5
AM - Armenia 4
BY - Bielorussia 4
CR - Costa Rica 4
ET - Etiopia 4
JM - Giamaica 4
KR - Corea 4
LT - Lituania 4
PS - Palestinian Territory 4
PT - Portogallo 4
RS - Serbia 4
TW - Taiwan 4
BH - Bahrain 3
DK - Danimarca 3
GE - Georgia 3
GT - Guatemala 3
QA - Qatar 3
TN - Tunisia 3
AU - Australia 2
EE - Estonia 2
KH - Cambogia 2
LB - Libano 2
MD - Moldavia 2
NI - Nicaragua 2
PA - Panama 2
RO - Romania 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AO - Angola 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CW - ???statistics.table.value.countryCode.CW??? 1
GA - Gabon 1
GD - Grenada 1
GR - Grecia 1
HR - Croazia 1
KW - Kuwait 1
MM - Myanmar 1
MN - Mongolia 1
Totale 12.703
Città #
Singapore 849
Moscow 772
Dublin 642
Ashburn 548
Chandler 538
Dallas 386
Nyköping 336
Hong Kong 333
San Jose 256
Beijing 211
Princeton 148
New York 121
Dearborn 115
Jacksonville 112
Medford 111
Los Angeles 103
The Dalles 98
Ann Arbor 90
Lauterbourg 86
Des Moines 84
São Paulo 81
Pune 70
Buffalo 53
Munich 51
Messina 49
Santa Clara 46
Redondo Beach 44
Wilmington 42
Council Bluffs 40
Warsaw 39
Cambridge 34
Ho Chi Minh City 33
Belo Horizonte 27
Guangzhou 27
Orem 27
Frankfurt am Main 26
Tianjin 26
Hanoi 25
Jinan 25
Rio de Janeiro 24
Brussels 21
Brasília 20
London 20
Milan 19
Nanjing 19
Shenyang 19
Baghdad 18
Montreal 18
Tokyo 18
Turku 18
Brooklyn 17
Curitiba 17
Nuremberg 17
Tashkent 16
Zhengzhou 16
Atlanta 15
San Francisco 15
Seattle 15
Washington 15
Falls Church 14
Shanghai 14
Catania 13
Chicago 13
Chennai 12
Johannesburg 12
Ningbo 12
Boardman 11
Hebei 11
Houston 11
Porto Alegre 11
San Mateo 11
Stockholm 11
Amsterdam 10
Hangzhou 10
Phoenix 10
Toronto 10
Boston 9
Cape Town 9
Changsha 9
Guarulhos 9
Hyderabad 9
Nairobi 9
Rome 9
Vienna 9
Woodbridge 9
Asunción 8
Baku 8
Campinas 8
Denver 8
Haikou 8
Paris 8
Poplar 8
Recife 8
Ribeirão Preto 8
Sorocaba 8
Amman 7
Dhaka 7
Grammichele 7
Helsinki 7
Istanbul 7
Totale 7.453
Nome #
CORRELATION BETWEEN DISEASE ACTIVITY AND CARDIOVASCULAR PARAMETERS IN PATIENTS WITH ANKYLOSING SPONDYLITIS 198
Adverse events, clinical considerations and management recommendations in rheumatoid arthritis patients treated with JAK inhibitors 192
CARDIOVASCULAR EVALUATION USING NON-INVASIVE IMAGING METHODS IN PATIENTS WITH ANKYLOSING SPONDYLITIS BEFORE AND AFTER 12 MONTHS OF TREATMENT WITH ANTI-TNF DRUGS 189
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 186
Algo-dysfunctional syndromes: a critical digest of the recent literature 185
Certainties and uncertainties concerning the contribution of pericytes to the pathogenesis of systemic sclerosis 175
CORRELATION BETWEEN SERUM LEVELS OF SCL-70 AUTO-ANTIBODIES AND SUBCLINICAL LV SYSTOLIC DYSFUNCTION IN PATIENTS WITH SYSTEMIC SCLEROSIS 175
Anti-tumour necrosis factor-α antibodies and B cell homeostasis in human inflammatory bowel diseases 173
Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents 169
SYSTEMIC SCLEROSIS AND CHRONIC GRAFT-VERSUS-HOST DISEASE SCLERODERMA-LIKE HAVE OTHER SIMILAR PATHOGENETIC MECHANISMS THAN STIMULATORY AUTOANTIBODIES TO PDGFR? 167
Densità minerale ossea, parametri ultrasonografici e metabolismo osseo in pazienti affetti da sclerosi sistemica. 162
Densità minerale ossea, parametri ultrasonografici e metabolismo osseo in pazienti affetti da sclerosi sistemica. 162
CHRONIC PAIN AND DEPRESSION: PAIN THRESHOLD AND VISUAL ANALOGUE SCALE. 162
Biomarkers in Rheumatoid Arthritis 162
BODY MASS INDEX, SMOKING STATUS AND RESPONSE TO RITUXIMAB IN RHEUMATOID ARTHRITIS: A REAL-LIFE STUDY. 160
Calcium physiology, metabolism and supplementation: a glance at patients with ankylosing spondylitis 157
Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: The straw that breaks the camel's back? 151
effetti dell'acido ialuronico sulla qualità di vita in pazienti affetti da osteoartrosi 150
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: A case series 150
CLINICAL AND ULTRASONOGRAPHIC EVALUATION IN A COHORT OF SUSTAINED REMISSION RHEUMATOID ARTHRITIS PATIENTS AFTER STOPPING BIOLOGIC THERAPY: A SINGLE CENTER EXPERIENCE , 150
SUBCLINICAL HYPERCORTISOLISM IS A RISK FACTOR TO BE EVALUATED IN THE ASSESSMENT OF BONE FRAGILITY? 148
Reasons Why Patients Failed Vaccinations Vs Influenza and Pneumococcus. Monocentric Cross-Sectional Study 143
RELATIONSHIP BETWEEN ULTRASONOGRAPHIC SALIVARY GLANDS ABNORMALITIES AND SUBCLINICAL CARDIOVASCULAR INVOLVEMENT IN PATIENTS WITH PRIMARY SJÖGREN SYNDROME 137
Autoimmunity as the comet tail of COVID-19 pandemic 133
The microbiome in connective tissue diseases and vasculitides: An updated narrative review 130
THE THRESHOLD OF PAIN IN PATIENTS AFFECTED BY RHEUMATOID ARTHRITIS CORRELATES WITH ESR BUT NOT WITH ULTRASOUND SCORE. 130
Biological agents in rheumatoid arthritis: A cross-link between immune tolerance and immune surveillance 126
ACHILLES PAIN PERSISTENCE IN PATIENTS AFFECTED BY SPONDYLOARTHRITIS: ULTRASONOGRAPHIC AND BIOMECHANICAL STUDY. 125
Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab 125
Safety and Efficacy of Switching from Originator to CT-P13 Infliximab Biosimilar in Patients Affected By Spondyloarthritis. a 6-Month Observational Study 124
MEASUREMENT OF SERUM ALPHA-KLOTHO IN SYSTEMIC SCLEROSIS PATIENTS: RESULTS FROM A PIVOTAL STUDY. 124
From autoinflammation to autoimmunity: old and recent findings 119
One year in review 2019: fibromyalgia 118
AB0132 THE IMPACT OF FIBROMYALGIA AND FIBROMYALGIA-RELATED SYMPTOMS ON TREATMENT ADHERENCE IN A COHORT OF PATIENTS WITH RHEUMATIC DISEASES: RESULTS OF A PILOT CROSS-SECTIONAL STUDY 117
Influence of polymorphism -308 G/A of the TNF-α gene on high mobility group BOX-1 protein in rheumatoid and spondylo-arthritis patients 114
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of scleroderma spectrum 113
Paradoxical Expansion of Th1 and Th17 Lymphocytes in Rheumatoid Arthritis Following Infliximab Treatment: a Possible Explanation for a Lack of Clinical Response 112
Immunogenicity and autoimmunity during anti-TNF therapy 110
Hyperbaric oxygen treatment of fibromyalgia: a prospective observational clinical trial 110
Ultrasonographyc Evaluation of Metacarpophalangeal Joints Can be Useful in the Differential Diagnosis of Early Rheumatoid Arthritis and Early Spondyloarthritis. A Monocentric Preliminary Study 109
JAK-Inhibitors for the Treatment of Rheumatoid Arthritis: A Focus on the Present and an Outlook on the Future 107
Motor cortex tRNS improves pain, affective and cognitive impairment in patients with fibromyalgia: preliminary results of a randomised sham-controlled trial 107
Retrotransposons shuttling genetic and epigenetic information from the nuclear to the mitochondrial compartment: Do they play a pathogenetic role in scleroderma? 106
Riniti persistenti da un punto di vista immunologico 105
Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases” 105
Psoriatic arthritis: From pathogenesis to pharmacologic management 104
VITAMIN D LEVELS AND BONE MINERAL DENSITY IN SYSTEMIC SCLEROSIS. 103
What are the dangers of biological therapy discontinuation or dose reduction strategies when treating rheumatoid arthritis? 103
THE CORRELATION BETWEEN CTLA4, CD80 AND CD86 GENE POLYMORPHISMS AND CLINICAL RESPONSE IN PATIENTS AFFECTED BY RHEUMATOID ARTHRITIS TREATED WITH ABATACEPT. 101
Vitamin D levels and bone mineral density in systemic sclerosis 101
Pain in systemic sclerosis 101
Differential Diagnosis of Vasovagal Syncope: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. 101
Efficacy of Cannabis Flos in Patients with Fibromyalgia: A Monocentric 101
Efficacy and Safety of Biosimilar and Originator Etanercept in Rheumatoid Arthritis Patients: Real-Life Data 101
Mental effects of physical activity in patients with fibromyalgia: a narrative review 100
Measurement of Serum Klotho in Systemic Sclerosis 100
Rheumatic Diseases and Biosimilars: Evidence about Switch from Originators to Biosimilars in the Real Life 100
Influence of Polymorphism at Position-308 of the Tumour Necrosis Factor Alpha Gene on the Expression of High Mobility Group Box-1 Protein in Rheumatoid Arthritis and Spondyloarthritis patient. 99
DOSE REDUCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS RESPONDING TO THE STANDARD RITUXIMAB REGIMEN. 99
Patients Failing to Fulfill 2016 Criteria for Fibromyalgia Represent a Truly Different Population Subset 99
PAIN INTENSITY AND THRESHOLD IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS PATIENTS: CORRELATIONS WITH THE HAMILTON DEPRESSION RATING SCALE 98
Non-pharmacological interventions for treating psoriatic arthritis 97
The effect of therapeutic exercise and local cryotherapy on lower limb enthesitis in non-radiographic axial spondyloarthritis: a case report 95
Infections and Biological Therapy in Patients with Rheumatic Diseases 95
PREVALENCE OF CHRONIC WIDESPREAD PAIN IN SSC PATIENTS: PRELIMINARY DATA 95
GENISTEIN PREVENTS QUALITY OF LIFE OSTEOPENIC POST- MENOPAUSAL WOMENS: A 2-YEAR RANDOMIZED, DOUBLE-BLIND, CONTROLLED-STUDY. 94
SDAI AS PREDICTOR OF 1-YEAR EFFICACY OF THE FIRST TNF BLOCKER IN CLINICAL PRACTICE. 94
Patologie respiratorie allergiche e miceti: casistica personale. 93
Reactivation of occult hepatitis B virus infection under treatment with abatacept: A case report 90
Serum klotho concentrations inversely correlate with the severity of nailfold capillaroscopic patterns in patients with systemic sclerosis 89
Glucocorticoidi nell’artrite reumatoide ed esperienze cliniche dell’uso di prednisone a rilascio modificato 88
Pain Intensity and Threshold in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients: Correlations with the Hamilton Depression Rating Scale 87
Novel pharmaceutical options for treating fibromyalgia 87
Ultrasonographic Evaluation of the Enthesis in Patients Affected By Entheropatic Spondiloarthritis. Focus on Distal Enthesis of the Patellar Tendon 86
Skin scores of patients with systemic sclerosis correlate with circulating thyrotropin levels 85
PREVALENCE AND EPIDEMIOLOGY OF FAMILIAL MEDITERRANEAN FEVER AND TUMOR NECROSIS FACTORRECEPTOR-ASSOCIATED PERIODIC SYNDROME: RESULTS FROM AN ITALIAN CENTER 85
Physical activity in idiopathic inflammatory myopathies: two intervention proposals based on literature review 85
Investigating the potential side effects of anti-TNF therapy for rheumatoid arthritis: cause for concern? 84
SAFETEY AND EFFICACY OF DIRECT-ACTING ANTIVIRAL AGENTS FOR THE TREATMENT OF HCV IN RHEUMATIC DISEASES: CASE SERIES 83
Earthquake vulnerability of fibromyalgia patients: six-month follow-up after the catastrophic disasters in central Italy 82
IL RUOLO DI KLOTHO NELLA SCLEROSI SISTEMICA 82
FATIGUE IN FIBROMYALGIA REFLECTS OVERALL BURDEN OF DISEASE 82
The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis 81
Possible relationship between certolizumab pegol and arrhythmias: Report of two cases 81
Pamidronate Treatment of Osteonecrosis of the Hip in Young Male. 81
PARADOXICAL EXPANSION OF TH1 AND TH17 CELLS IN PERIPHERAL CULTURAL BLOOD CELLS OF RA PATIENTS FOLLOWING INFLIXIMAB TREATMENT: A POSSIBLE CORRELATION WITH LOSS OF CLINICAL RESPONSE AND ADVERSE EVENTS 81
The role of klotho in systemic sclerosis 80
The preventive and therapeutic role of physical activity in knee osteoarthritis 79
Evaluation of Th9 lymphocytes in peripheral blood of rheumatoid arthritis patients and correlation with anti-tumor necrosis factor therapy: results from an in vitro pivotal study 78
The contribution of HERV-E clone 4-1 and other HERV-E members to the pathogenesis of rheumatic autoimmune diseases. 76
POTENTIAL ROLE OF METACARPOPHALANGEAL JOINTS ULTRASOUND IN THE DIFFERENTIAL DIAGNOSIS BETWEEN EARLY RHEUMATOID ARTHRITIS AND EARLY SPONDYLOARTHRITIS 75
Pros and cons of the immunogenicity of monoclonal antibodies in cancer treatment: A lesson from autoimmune diseases 74
Evaluation of salivary and plasma microRNA expression in patients with Sjogren's syndrome, and correlations with clinical and ultrasonographic outcomes 73
Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort 73
Baicalin as a potential candidate for treating systemic sclerosis 72
Spondyloarthritis and Gastrointestinal Involvement 72
Retroviruses in the pathogenesis of systemic lupus erythematosus: Are they potential therapeutic targets? 72
Fibromialgia 71
Evaluation of salivary mirnas in patients affected by sjÖgren’s syndrome and correlation with clinical and ultrasonographic outcomes. 71
The rationale for targeting the JAK/STAT pathway in scleroderma-associated interstitial lung disease 71
Totale 11.202
Categoria #
all - tutte 48.689
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.689


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022655 0 38 16 27 42 17 41 33 14 36 34 357
2022/20231.875 146 193 124 153 71 189 32 105 785 11 49 17
2023/2024511 44 55 19 35 40 192 2 16 6 32 8 62
2024/20252.469 42 15 38 163 130 77 95 518 630 119 232 410
2025/20266.318 272 401 433 319 507 1.477 868 706 641 371 89 234
2026/2027146 141 5 0 0 0 0 0 0 0 0 0 0
Totale 13.090